Yimutian receives Nasdaq approval to transfer to Capital Market

Yimutian Inc. (YMT) won Nasdaq approval to transfer from the Nasdaq Global Market to the Nasdaq Capital Market, but it must regain compliance with the $1.00 minimum bid by Sep 29, 2026 and $2.5m stockholders’ equity by Sep 30, 2026. The stock trades at $0.52 (down 99% from its $90.75 52-week high) despite $20.11m in trailing-12-month revenue and a loss of $1.87/share with negative stockholders’ equity. Separately, the company reported its WolaiCai AI Agent is fully deployed (200M+ tokens/day; ~$3,000/day revenue) and plans a 15-for-1 ADS reverse split around May 18, 2026.

Analysis

This is a capital-structure story, not a turnaround. The exchange move and future reverse split mainly preserve optionality for insiders and management while pushing common holders further down the priority ladder; for a sub-$5m equity with negative book value, the only realistic way to “fix” compliance is dilution or mechanical share consolidation, neither of which creates intrinsic value. The market should treat any strength as technical unless operating cash burn visibly inflects.

The second-order effect is that the stock becomes more tradeable as a squeeze vehicle but less investable for real capital. That usually benefits market makers and short-term momentum traders, while harming long-only holders who get trapped by widening spreads, borrow scarcity, and repeated reset events. The tiny AI-revenue narrative is economically irrelevant versus the cash burn, so it does not change runway math unless it is paired with a meaningful strategic investor or non-dilutive financing.

Time horizon matters: over the next few days, the event can support a reflex rally on headline flow; over 1-3 months, the real catalyst is whether management files a dilutive raise, executes the split, or misses the compliance timeline again; over 6-18 months, the base case remains either continued erosion or a corporate-action-driven exit, not fundamental re-rating. Contrarian bulls will argue the float shrink plus China-speculation can create outsized upside, but that is a trading setup, not a thesis. The thesis is falsified only if the company sustains a >$1 post-split bid on real volume while reducing burn and rebuilding equity, which currently looks unlikely.

Key Decisions for Investors

• Avoid initiating a long YMT position; the cleanest expression is to sell any post-news/ post-split liquidity pop if borrow is available, with the view that the move is technical and should fade within days to weeks.
• If a short is feasible, use YMT as a tactical microcap short only after a reverse-split or announcement-driven spike; position small because borrow, spreads, and squeeze risk can overwhelm fundamentals.
• Set an alert for any equity financing, ATM facility, or strategic investor disclosure between now and the 2026 compliance deadlines; a raise would confirm dilution risk and materially strengthen the bearish case.
• Relative-value alternative: avoid the name entirely and rotate exposure to higher-quality China internet/ag-commerce proxies rather than trying to hedge this with a broad China basket, since YMT’s idiosyncratic liquidity risk is too extreme for clean pairing.
• Use a hard invalidation level at a sustained, post-split-equivalent reclaim of $1 on heavy volume accompanied by improving equity/cash flow; without that, any bullish thesis is just optionality trading.